RNA expression of complement regulatory proteins in human brain tumors
The expression of complement regulatory proteins (CRP) on the surface of neoplastic cells has been proposed as a mechanism by which these cells evade immune surveillance. We have examined the RNA expression of the genes that encode 5 kinds of CRP in various human brain tumors to determine whether CR...
Gespeichert in:
Veröffentlicht in: | Cancer letters 1994-11, Vol.86 (2), p.143-149 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 149 |
---|---|
container_issue | 2 |
container_start_page | 143 |
container_title | Cancer letters |
container_volume | 86 |
creator | Shinoura, Nobusada Heffelfinger, Sue C. Miller, Maryann Shamraj, Olga I. Miura, Nam-Ho C. Larson, Jeffrey J. DeTribolet, Nicolet Warnick, Ronald E. Tew, John J. Menon, Anil G. |
description | The expression of complement regulatory proteins (CRP) on the surface of neoplastic cells has been proposed as a mechanism by which these cells evade immune surveillance. We have examined the RNA expression of the genes that encode 5 kinds of CRP in various human brain tumors to determine whether CRP expression might play a role in the malignant progression of these tumors. The benign and atypical meningiomas, and the astrocytomas showed high expression of SP-40,40, low expression of CD59, and barely detectable expression of CD46, CD55 and
S-protein. The benign and atypical menigiomas showed significantly greater expression of SP-40,40 at the RNA level when compared to malignant meningiomas. This study describes the mRNA expression of meningiomas, astrocytomas, tumor cell lines and normal human tissues. |
doi_str_mv | 10.1016/0304-3835(94)90072-8 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76856748</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0304383594900728</els_id><sourcerecordid>76856748</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-268f5a65b28fbd47d2f8fae848e9ff50cdd2f7c8a66a93f045589507de4e149a3</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRaq3-A4UcRPQQ3ST7eRFKsSoUBdHzst3M6kqSrbuJ2H9vYkuPnmaY95lheBA6zfB1hjN2gwtM0kIU9FKSK4kxz1Oxh8aZ6BsuBd5H4x1yiI5i_MQYU8LpCI04zZnk-RjNX56mCfysAsTofJN4mxhfryqooWmTAO9dpVsf1skq-BZcExPXJB9drZtkGXTft13tQzxGB1ZXEU62dYLe5nevs4d08Xz_OJsuUlMI1qY5E5ZqRpe5sMuS8DK3wmoQRIC0lmJT9hNuhGZMy8JiQqmQFPMSCGRE6mKCLjZ3-3e-Ooitql00UFW6Ad9FxZmgjBPRg2QDmuBjDGDVKrhah7XKsBr0qcGNGtwoSdSfPjWsnW3vd8sayt3S1lefn29zHY2ubNCNcXGHFUUmJME9drvBoHfx7SCoaBw0BkoXwLSq9O7_P34B9gSMBA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76856748</pqid></control><display><type>article</type><title>RNA expression of complement regulatory proteins in human brain tumors</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Shinoura, Nobusada ; Heffelfinger, Sue C. ; Miller, Maryann ; Shamraj, Olga I. ; Miura, Nam-Ho C. ; Larson, Jeffrey J. ; DeTribolet, Nicolet ; Warnick, Ronald E. ; Tew, John J. ; Menon, Anil G.</creator><creatorcontrib>Shinoura, Nobusada ; Heffelfinger, Sue C. ; Miller, Maryann ; Shamraj, Olga I. ; Miura, Nam-Ho C. ; Larson, Jeffrey J. ; DeTribolet, Nicolet ; Warnick, Ronald E. ; Tew, John J. ; Menon, Anil G.</creatorcontrib><description>The expression of complement regulatory proteins (CRP) on the surface of neoplastic cells has been proposed as a mechanism by which these cells evade immune surveillance. We have examined the RNA expression of the genes that encode 5 kinds of CRP in various human brain tumors to determine whether CRP expression might play a role in the malignant progression of these tumors. The benign and atypical meningiomas, and the astrocytomas showed high expression of SP-40,40, low expression of CD59, and barely detectable expression of CD46, CD55 and
S-protein. The benign and atypical menigiomas showed significantly greater expression of SP-40,40 at the RNA level when compared to malignant meningiomas. This study describes the mRNA expression of meningiomas, astrocytomas, tumor cell lines and normal human tissues.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/0304-3835(94)90072-8</identifier><identifier>PMID: 7526972</identifier><identifier>CODEN: CALEDQ</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Antigens, CD - genetics ; Astrocytoma - genetics ; Base Sequence ; Biological and medical sciences ; Brain Neoplasms - genetics ; Brain tumor ; CD55 Antigens ; CD59 ; CD59 Antigens ; Clusterin ; Complement Inactivator Proteins - genetics ; Complement regulatory protein ; Glycoproteins ; Humans ; Medical sciences ; Membrane Cofactor Protein ; Membrane Glycoproteins - genetics ; Meningioma - genetics ; Molecular Chaperones ; Molecular Sequence Data ; Neurology ; RNA - analysis ; SP40,40 ; Tumor Cells, Cultured ; Tumors of the nervous system. Phacomatoses ; Vitronectin</subject><ispartof>Cancer letters, 1994-11, Vol.86 (2), p.143-149</ispartof><rights>1994</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-268f5a65b28fbd47d2f8fae848e9ff50cdd2f7c8a66a93f045589507de4e149a3</citedby><cites>FETCH-LOGICAL-c386t-268f5a65b28fbd47d2f8fae848e9ff50cdd2f7c8a66a93f045589507de4e149a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0304383594900728$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3318940$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7526972$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shinoura, Nobusada</creatorcontrib><creatorcontrib>Heffelfinger, Sue C.</creatorcontrib><creatorcontrib>Miller, Maryann</creatorcontrib><creatorcontrib>Shamraj, Olga I.</creatorcontrib><creatorcontrib>Miura, Nam-Ho C.</creatorcontrib><creatorcontrib>Larson, Jeffrey J.</creatorcontrib><creatorcontrib>DeTribolet, Nicolet</creatorcontrib><creatorcontrib>Warnick, Ronald E.</creatorcontrib><creatorcontrib>Tew, John J.</creatorcontrib><creatorcontrib>Menon, Anil G.</creatorcontrib><title>RNA expression of complement regulatory proteins in human brain tumors</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>The expression of complement regulatory proteins (CRP) on the surface of neoplastic cells has been proposed as a mechanism by which these cells evade immune surveillance. We have examined the RNA expression of the genes that encode 5 kinds of CRP in various human brain tumors to determine whether CRP expression might play a role in the malignant progression of these tumors. The benign and atypical meningiomas, and the astrocytomas showed high expression of SP-40,40, low expression of CD59, and barely detectable expression of CD46, CD55 and
S-protein. The benign and atypical menigiomas showed significantly greater expression of SP-40,40 at the RNA level when compared to malignant meningiomas. This study describes the mRNA expression of meningiomas, astrocytomas, tumor cell lines and normal human tissues.</description><subject>Antigens, CD - genetics</subject><subject>Astrocytoma - genetics</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Brain Neoplasms - genetics</subject><subject>Brain tumor</subject><subject>CD55 Antigens</subject><subject>CD59</subject><subject>CD59 Antigens</subject><subject>Clusterin</subject><subject>Complement Inactivator Proteins - genetics</subject><subject>Complement regulatory protein</subject><subject>Glycoproteins</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Membrane Cofactor Protein</subject><subject>Membrane Glycoproteins - genetics</subject><subject>Meningioma - genetics</subject><subject>Molecular Chaperones</subject><subject>Molecular Sequence Data</subject><subject>Neurology</subject><subject>RNA - analysis</subject><subject>SP40,40</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors of the nervous system. Phacomatoses</subject><subject>Vitronectin</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1Lw0AQhhdRaq3-A4UcRPQQ3ST7eRFKsSoUBdHzst3M6kqSrbuJ2H9vYkuPnmaY95lheBA6zfB1hjN2gwtM0kIU9FKSK4kxz1Oxh8aZ6BsuBd5H4x1yiI5i_MQYU8LpCI04zZnk-RjNX56mCfysAsTofJN4mxhfryqooWmTAO9dpVsf1skq-BZcExPXJB9drZtkGXTft13tQzxGB1ZXEU62dYLe5nevs4d08Xz_OJsuUlMI1qY5E5ZqRpe5sMuS8DK3wmoQRIC0lmJT9hNuhGZMy8JiQqmQFPMSCGRE6mKCLjZ3-3e-Ooitql00UFW6Ad9FxZmgjBPRg2QDmuBjDGDVKrhah7XKsBr0qcGNGtwoSdSfPjWsnW3vd8sayt3S1lefn29zHY2ubNCNcXGHFUUmJME9drvBoHfx7SCoaBw0BkoXwLSq9O7_P34B9gSMBA</recordid><startdate>19941111</startdate><enddate>19941111</enddate><creator>Shinoura, Nobusada</creator><creator>Heffelfinger, Sue C.</creator><creator>Miller, Maryann</creator><creator>Shamraj, Olga I.</creator><creator>Miura, Nam-Ho C.</creator><creator>Larson, Jeffrey J.</creator><creator>DeTribolet, Nicolet</creator><creator>Warnick, Ronald E.</creator><creator>Tew, John J.</creator><creator>Menon, Anil G.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19941111</creationdate><title>RNA expression of complement regulatory proteins in human brain tumors</title><author>Shinoura, Nobusada ; Heffelfinger, Sue C. ; Miller, Maryann ; Shamraj, Olga I. ; Miura, Nam-Ho C. ; Larson, Jeffrey J. ; DeTribolet, Nicolet ; Warnick, Ronald E. ; Tew, John J. ; Menon, Anil G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-268f5a65b28fbd47d2f8fae848e9ff50cdd2f7c8a66a93f045589507de4e149a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Antigens, CD - genetics</topic><topic>Astrocytoma - genetics</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Brain Neoplasms - genetics</topic><topic>Brain tumor</topic><topic>CD55 Antigens</topic><topic>CD59</topic><topic>CD59 Antigens</topic><topic>Clusterin</topic><topic>Complement Inactivator Proteins - genetics</topic><topic>Complement regulatory protein</topic><topic>Glycoproteins</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Membrane Cofactor Protein</topic><topic>Membrane Glycoproteins - genetics</topic><topic>Meningioma - genetics</topic><topic>Molecular Chaperones</topic><topic>Molecular Sequence Data</topic><topic>Neurology</topic><topic>RNA - analysis</topic><topic>SP40,40</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors of the nervous system. Phacomatoses</topic><topic>Vitronectin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shinoura, Nobusada</creatorcontrib><creatorcontrib>Heffelfinger, Sue C.</creatorcontrib><creatorcontrib>Miller, Maryann</creatorcontrib><creatorcontrib>Shamraj, Olga I.</creatorcontrib><creatorcontrib>Miura, Nam-Ho C.</creatorcontrib><creatorcontrib>Larson, Jeffrey J.</creatorcontrib><creatorcontrib>DeTribolet, Nicolet</creatorcontrib><creatorcontrib>Warnick, Ronald E.</creatorcontrib><creatorcontrib>Tew, John J.</creatorcontrib><creatorcontrib>Menon, Anil G.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shinoura, Nobusada</au><au>Heffelfinger, Sue C.</au><au>Miller, Maryann</au><au>Shamraj, Olga I.</au><au>Miura, Nam-Ho C.</au><au>Larson, Jeffrey J.</au><au>DeTribolet, Nicolet</au><au>Warnick, Ronald E.</au><au>Tew, John J.</au><au>Menon, Anil G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RNA expression of complement regulatory proteins in human brain tumors</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>1994-11-11</date><risdate>1994</risdate><volume>86</volume><issue>2</issue><spage>143</spage><epage>149</epage><pages>143-149</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><coden>CALEDQ</coden><abstract>The expression of complement regulatory proteins (CRP) on the surface of neoplastic cells has been proposed as a mechanism by which these cells evade immune surveillance. We have examined the RNA expression of the genes that encode 5 kinds of CRP in various human brain tumors to determine whether CRP expression might play a role in the malignant progression of these tumors. The benign and atypical meningiomas, and the astrocytomas showed high expression of SP-40,40, low expression of CD59, and barely detectable expression of CD46, CD55 and
S-protein. The benign and atypical menigiomas showed significantly greater expression of SP-40,40 at the RNA level when compared to malignant meningiomas. This study describes the mRNA expression of meningiomas, astrocytomas, tumor cell lines and normal human tissues.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>7526972</pmid><doi>10.1016/0304-3835(94)90072-8</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0304-3835 |
ispartof | Cancer letters, 1994-11, Vol.86 (2), p.143-149 |
issn | 0304-3835 1872-7980 |
language | eng |
recordid | cdi_proquest_miscellaneous_76856748 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Antigens, CD - genetics Astrocytoma - genetics Base Sequence Biological and medical sciences Brain Neoplasms - genetics Brain tumor CD55 Antigens CD59 CD59 Antigens Clusterin Complement Inactivator Proteins - genetics Complement regulatory protein Glycoproteins Humans Medical sciences Membrane Cofactor Protein Membrane Glycoproteins - genetics Meningioma - genetics Molecular Chaperones Molecular Sequence Data Neurology RNA - analysis SP40,40 Tumor Cells, Cultured Tumors of the nervous system. Phacomatoses Vitronectin |
title | RNA expression of complement regulatory proteins in human brain tumors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T23%3A47%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RNA%20expression%20of%20complement%20regulatory%20proteins%20in%20human%20brain%20tumors&rft.jtitle=Cancer%20letters&rft.au=Shinoura,%20Nobusada&rft.date=1994-11-11&rft.volume=86&rft.issue=2&rft.spage=143&rft.epage=149&rft.pages=143-149&rft.issn=0304-3835&rft.eissn=1872-7980&rft.coden=CALEDQ&rft_id=info:doi/10.1016/0304-3835(94)90072-8&rft_dat=%3Cproquest_cross%3E76856748%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76856748&rft_id=info:pmid/7526972&rft_els_id=0304383594900728&rfr_iscdi=true |